SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Gold/Mining/Energy : Canadian-under $3.00 Stock-Picking Challenge -- Ignore unavailable to you. Want to Upgrade?


To: geoffb_si who wrote (6909)3/3/2002 4:10:17 PM
From: Al Collard  Respond to of 11802
 
Hi Geoff,

Your in with ONC-t @$2.80 for 3,571 shares.

Chart for Oncolytics Biotech, Inc:

stockcharts.com[h,a]daclyiay[pc20!b50][vc60][iLa12,26,9!Ll14]&pref=G

From the chart of ONC we can see the stock has resistance @$3.08 it's 20EMA. The big gap down from $6.25 sticks out like a sore thumb on this chart and it is one that will need some real good news to get filled, but it is still in the realm of possibilities. Good Phase 1 results just might be the spark this stock needs to right itself.

Good luck with this pick,
Al



To: geoffb_si who wrote (6909)3/4/2002 3:04:03 PM
From: Al Collard  Read Replies (1) | Respond to of 11802
 
ONC-t...in the news:

Oncolytics Announces Webcast of Presentation at Seattle's Invest Northwest Conference

newswire.ca



To: geoffb_si who wrote (6909)3/7/2002 8:37:43 AM
From: Al Collard  Read Replies (1) | Respond to of 11802
 
ONC-t...in the news:

Results of Reovirus Research to be Presented at the 2002 Annual Meeting of the American Association for Cancer Research

newswire.ca



To: geoffb_si who wrote (6909)3/8/2002 8:51:34 AM
From: Al Collard  Respond to of 11802
 
ONC-t...in the news:

Oncolytics Biotech Inc. Files Application With U.S. FDA To Initiate Phase I/II Recurrent Glioma Trial

newswire.ca